InsidersTradesSigma
Follow the 睿昂基因 stock price and the full management transaction log of the company, a listed equity based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 睿昂基因 has recorded 2 reports. Market capitalisation: €1.1bn. The latest transaction was disclosed on 12 September 2023 (Sale). Among the most active insiders: 柯中和. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
睿昂基因是一家专注于健康和制药领域的公司，专门从事创新基因解决方案的开发。该公司在上海证券交易所上市。